DOI QR코드

DOI QR Code

MiR-133b Acts as a Tumor Suppressor and Negatively Regulates TBPL1 in Colorectal Cancer Cells

  • Xiang, Kai-Min (Department of General Surgery, The Third XiangYa Hospital of Central-South University) ;
  • Li, Xiao-Rong (Department of General Surgery, The Third XiangYa Hospital of Central-South University)
  • Published : 2014.04.30

Abstract

Introduction: MicroRNAs have emerged as post-transcriptional regulators that are critically involved in tumorigenesis. This study was designed to explore the effect of miRNA 133b on the proliferation and expression of TBPL1 in colon cancer cells. Methods: Human colon cancer SW-620 cells and human colon adenocarcinoma HT-29 cells were cultured. MiRNA 133b mimcs, miRNA 133b inhibitors, siRNA for TBPL1 and scrambled control were synthesized and transfected into cells. MiR-133b levels in cells and CRC tumor tissue was measured by real-time PCR. TBPL1 mRNA was detected by RT-PCR. Cell proliferation was studied with MTT assay. Western blotting was applied to detect TBPL1 protein levels. Luciferase assays were conducted using a pGL3-promoter vector cloned with full length of 3'UTR of human TBPL1 or 3'UTR with mutant sequence of miR-133b target site in order to confirm if the putative binding site is responsible for the negative regulation of TBPL1 by miR-133b. Results: Real time PCR results showed that miRNA 133b was lower in CRC tissue than that in adjacent tissue. After miR-133b transfection, its level was elevated till 48h, accompanied by lower proliferation in both SW-620 and HT-29 cells. According to that listed in http://www.targetscan.org, the 3'-UTR of TBPL1 mRNA (NM_004865) contains one putative binding site of miR-133b. This site was confirmed to be responsible for the negative regulation by miR-133b with luciferase assay. Further, Western blotting and immunohistochemistry both indicated a higher TBPL1 protein expression level in CRC tissue. Finally, a siRNA for TBPL1 transfection obviously slowed down the cell proliferation in both SW-620 and HT-29 cells. Conclusion: MiR-133b might act as a tumor suppressor and negatively regulate TBPL1 in CRC.

Acknowledgement

Supported by : National Natural Science Foundation of China

References

  1. Aghili M, Izadi S, Madani H, et al (2010). Clinical and pathological evaluation of patients with early and late recurrence of colorectal cancer. Asia Pac J Clin Oncol, 6, 35-41. https://doi.org/10.1111/j.1743-7563.2010.01275.x
  2. Ambros V (2004). The functions of animal microRNAs. Nature, 431, 350-5. https://doi.org/10.1038/nature02871
  3. Ayude D, Rodriguez-Berrocal FJ, Ayude J, et al (2013). Preoperative serum CA 72.4 as prognostic factor of recurrence and death, especially at TNM stage II, for colorectal cancer. BMC Cancer, 13, 543. https://doi.org/10.1186/1471-2407-13-543
  4. Bandres E, Cubedo E, Agirre X, et al (2006). Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol cancer, 5, 29.
  5. Dantonel JC, Wurtz JM, Poch O, et al (1999). The TBP-like factor: an alternative transcription factor in metazoa? Trends Biochem Sci, 24, 335-9. https://doi.org/10.1016/S0968-0004(99)01436-X
  6. Ehrig K, Kilinc MO, Chen NG, et al (2013). Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68. J Transl Med, 11, 79. https://doi.org/10.1186/1479-5876-11-79
  7. Esquela-Kerscher A, Slack FJ (2006). Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer, 6, 259-69. https://doi.org/10.1038/nrc1840
  8. Farh KK, Grimson A, Jan C, et al (2005). The widespread impact of mammalian MicroRNAs on mRNA repression and evolution. Science, 310, 1817-21. https://doi.org/10.1126/science.1121158
  9. Fetemeh H, Saeed A, Amir M, Mehdi E (2014). Clinicopathological features of colon adenocarcinoma in Qazvin, Iran: a 16 year study. Asian Pac J Cancer Prev, 15, 951-5. https://doi.org/10.7314/APJCP.2014.15.2.951
  10. Jacobi UG, Akkers RC, Pierson ES, et al (2007). TBP paralogs accommodate metazoan- and vertebrate-specific developmental gene regulation. EMBO J, 26, 3900-9. https://doi.org/10.1038/sj.emboj.7601822
  11. Koutsoulidou A, Mastroyiannopoulos NP, Furling D, et al (2011). Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle. BMC Dev Biol, 11, 34. https://doi.org/10.1186/1471-213X-11-34
  12. Lim LP, Lau NC, Garrett-Engele P, et al (2005). Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature, 433, 769-73. https://doi.org/10.1038/nature03315
  13. Lim LP, Lau NC, Weinstein EG, et al (2003). The microRNAs of Caenorhabditis elegans. Genes Dev, 17, 991-1008. https://doi.org/10.1101/gad.1074403
  14. Lin M, Chen W, Huang J, et al (2011). MicroRNA expression profiles in human colorectal cancers with liver metastases. Oncol Rep, 25, 739-47.
  15. Lu J, Getz G, Miska EA, et al (2005). MicroRNA expression profiles classify human cancers. Nature, 435, 834-8. https://doi.org/10.1038/nature03702
  16. Martianov I, Brancorsini S, Gansmuller A, et al (2002). Distinct functions of TBP and TLF/TRF2 during spermatogenesis: requirement of TLF for heterochromatic chromocenter formation in haploid round spermatids. Development, 129, 945-55.
  17. Novello C, Pazzaglia L, Cingolani C, et al (2013). miRNA expression profile in human osteosarcoma: role of miR-1 and miR-133b in proliferation and cell cycle control. Int J Oncol, 42, 667-75.
  18. Panguluri SK, Bhatnagar S, Kumar A, et al (2010). Genomic profiling of messenger RNAs and microRNAs reveals potential mechanisms of TWEAK-induced skeletal muscle wasting in mice. PloS One, 5, e8760. https://doi.org/10.1371/journal.pone.0008760
  19. Schickel R, Boyerinas B, Park SM, et al (2008). MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene, 27, 5959-74. https://doi.org/10.1038/onc.2008.274
  20. Sun K, Deng HJ, Lei ST, et al (2013). miRNA-338-3p suppresses cell growth of human colorectal carcinoma by targeting smoothened. World J Gastroenterol, 19, 2197-207. https://doi.org/10.3748/wjg.v19.i14.2197
  21. Vannini A, Cramer P (2012). Conservation between the RNA polymerase I, II, and III transcription initiation machineries. Mol Cell, 45, 439-46. https://doi.org/10.1016/j.molcel.2012.01.023
  22. Wen D, Li S, Ji F, et al (2013). miR-133b acts as a tumor suppressor and negatively regulates FGFR1 in gastric cancer. Tumour Biol, 34, 793-803. https://doi.org/10.1007/s13277-012-0609-7
  23. Yamamoto H, Kohashi K, Fujita A, et al (2013). Fascin-1 overexpression and miR-133b downregulation in the progression of gastrointestinal stromal tumor. Mod Pathol, 26, 563-71. https://doi.org/10.1038/modpathol.2012.198
  24. Yamasaki T, Yoshino H, Enokida H, et al (2012). Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer. Int J Oncol, 40, 1821-30.
  25. Zhou Y, Wu D, Tao J, et al (2013). MicroRNA-133 inhibits cell proliferation, migration and invasion by targeting epidermal growth factor receptor and its downstream effector proteins in bladder cancer. Scand J Urol, 47, 423-32. https://doi.org/10.3109/00365599.2012.748821

Cited by

  1. Enforced expression of miR-101 enhances cisplatin sensitivity in human bladder cancer cells by modulating the cyclooxygenase-2 pathway vol.10, pp.4, 2014, https://doi.org/10.3892/mmr.2014.2455
  2. MicroRNA-133b inhibits connective tissue growth factor in colorectal cancer and correlates with the clinical stage of the disease vol.11, pp.4, 2014, https://doi.org/10.3892/mmr.2014.3075
  3. MicroRNAs in Colorectal Cancer: from Diagnosis to Targeted Therapy vol.15, pp.17, 2014, https://doi.org/10.7314/APJCP.2014.15.17.6989
  4. GRP78 Secreted by Colon Cancer Cells Facilitates Cell Proliferation via PI3K/Akt Signaling vol.15, pp.17, 2014, https://doi.org/10.7314/APJCP.2014.15.17.7245
  5. Combined downregulation of microRNA-133a and microRNA-133b predicts chemosensitivity of patients with esophageal squamous cell carcinoma undergoing paclitaxel-based chemotherapy vol.31, pp.11, 2014, https://doi.org/10.1007/s12032-014-0263-6
  6. Decreased miR-154 expression and its clinical significance in human colorectal cancer vol.13, pp.1, 2015, https://doi.org/10.1186/s12957-015-0607-5
  7. Let-7b inhibits cell proliferation, migration, and invasion through targeting Cthrc1 in gastric cancer vol.36, pp.5, 2015, https://doi.org/10.1007/s13277-014-2950-5
  8. DNA methylation is involved in the aberrant expression of miR-133b in colorectal cancer cells pp.1792-1082, 2015, https://doi.org/10.3892/ol.2015.3336
  9. miR-133b, a microRNA targeting S1PR1, suppresses nasopharyngeal carcinoma cell proliferation vol.11, pp.4, 2016, https://doi.org/10.3892/etm.2016.3043
  10. MicroRNA-133b Negatively Regulates Zebrafish Single Mauthner-Cell Axon Regeneration through Targeting tppp3 in Vivo vol.10, pp.1662-5099, 2017, https://doi.org/10.3389/fnmol.2017.00375
  11. Investigating MicroRNA and transcription factor co-regulatory networks in colorectal cancer vol.18, pp.1, 2017, https://doi.org/10.1186/s12859-017-1796-4
  12. Colorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs vol.2017, pp.2314-6141, 2017, https://doi.org/10.1155/2017/7354260
  13. expression in the healthy human colorectal epithelium: A randomized controlled trial vol.56, pp.9, 2017, https://doi.org/10.1002/mc.22666
  14. Regulatory Roles of Non-Coding RNAs in Colorectal Cancer vol.16, pp.8, 2015, https://doi.org/10.3390/ijms160819886
  15. Prognostic Value of MicroRNAs in Preoperative Treated Rectal Cancer vol.17, pp.4, 2016, https://doi.org/10.3390/ijms17040568
  16. miR-133b acts as a tumor suppressor and negatively regulates ATP citrate lyase via PPARγ in gastric cancer vol.38, pp.5, 2017, https://doi.org/10.3892/or.2017.5944